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Introduction
About the effect of mild therapeutic hypothermia on
renal function after cardiopulmonary resuscitation little
data exists. From animal and human studies it is known
that renal function might be impaired, which is not
reflected by serum creatinine levels if creatinine produc-
tion is reduced.
Objectives
The aim of the study was to investigate the possible
influence of mild therapeutic hypothermia (MTH) on
the incidence of acute kidney injury (AKI) and renal
function parameters [1].
Methods
This is a retrospective analysis of prospectively collected
data on patients after successful cardiopulmonary resus-
citation (CPR) at our ICU. Serum creatinine and cystatin
C were measured at baseline, daily up to 5 days and at
ICU discharge. AKI was defined by the KDIGO criteria
(only based on creatinine values). MTH was applied for
24 hours targeting a temperature of 33°C using an intra-
vascular cooling device. Neurological outcome was
assessed with the Cerebral Performance Categories
(CPC) score at hospital discharge.
Results
55 of 126 patients were treated with MTH, 20 patients
received continuous renal replacement therapy, 62 of
126 patients had good neurological outcome (CPC 1-2).
In patients treated with MTH there was a significantly
lower incidence of AKI (9 vs 20; p = 0.007) accompa-
nied by significantly lower creatinine levels on day 1-2
and at ICU discharge (day 1: 1.12 (0.90-1.29) vs. 1.29
(1.00-1.52) mg/dl; p= 0.016) and lower cystatin C levels
on day 1-4 and ICU discharge (day 1: 0.88 (0.77-1.10)
vs. 1.29 (1.06-2.16)mg/l; p < 0.001). Restricting analysis
to patients with good neurological outcome confirmed a
significant lower creatinine on day 2 (0.82 (0.67-1.02) vs.
1.03 (0.83-1.38) mg/dl; p = 0.049) and cystatin C on day
1-2 when treated with MTH. In patients with poor neu-
rological outcome treated with MTH cystatin C levels
were also significantly lower on day 1-2 (day 1: 0.96
(0.83-1.30) vs. 1.44 (1.17- 2.29) mg/l; p = 0.01) and at
ICU discharge, whereas creatinine was only significantly
lower at ICU discharge (0.84 (0.51-1.36) vs. 1.23 (0.87-
2.15) mg/dl; p = 0.039). AKI occurred significantly less
often (10 vs. 35; p = 0.017) in this subgroup.
Conclusions
MTH seems to have a protective effect against the
development of AKI, especially in patients with poor
neurological outcome. Cystatin C seems to play a role
for determination of renal function in patients treated
with MTH.
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Figure 1 Serum cystatin C levels (mg/l) on day 1-5 and ICU
discharge in patients treated with mild therapeutic
hypothermia or normothermia.
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